Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data
View ORCID ProfileTijs W. Alleman, View ORCID ProfileJenna Vergeynst, Lander De Visscher, View ORCID ProfileMichiel Rollier, View ORCID ProfileElena Torfs, View ORCID ProfileIngmar Nopens, View ORCID ProfileJan M. Baetens
doi: https://doi.org/10.1101/2020.07.17.20156034
Tijs W. Alleman
1BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Jenna Vergeynst
1BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
2KERMIT, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Lander De Visscher
2KERMIT, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Michiel Rollier
2KERMIT, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Elena Torfs
1BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Ingmar Nopens
1BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Jan M. Baetens
2KERMIT, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, 9000 Gent, Belgium
Data Availability
All code and data is publically available on the BIOMATH GitHub repo (https://github.com/UGentBiomath/COVID19-Model/).
Posted July 27, 2021.
Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data
Tijs W. Alleman, Jenna Vergeynst, Lander De Visscher, Michiel Rollier, Elena Torfs, Ingmar Nopens, Jan M. Baetens
medRxiv 2020.07.17.20156034; doi: https://doi.org/10.1101/2020.07.17.20156034
Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data
Tijs W. Alleman, Jenna Vergeynst, Lander De Visscher, Michiel Rollier, Elena Torfs, Ingmar Nopens, Jan M. Baetens
medRxiv 2020.07.17.20156034; doi: https://doi.org/10.1101/2020.07.17.20156034
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2971)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12820)
- Forensic Medicine (12)
- Gastroenterology (831)
- Genetic and Genomic Medicine (4624)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2944)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4414)
- Nursing (238)
- Nutrition (653)
- Oncology (2298)
- Ophthalmology (653)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7010)
- Radiology and Imaging (1548)
- Respiratory Medicine (921)
- Rheumatology (445)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)